Pamisell has ranked among the top searched stocks for 12 days in the past month.
As of 2:31 PM on the 23rd, Pamisell is trading at 18,400 KRW, the same price as the previous day. This represents an 18.94% decrease compared to August 26. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Today, foreigners are tentatively recorded as net buyers of 59,728 shares. Over the past five days, individual investors have net purchased 114,170 shares, while foreigners and institutions have net sold 113,942 shares and 1,246 shares, respectively.


※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
